PMID- 22465806 OWN - NLM STAT- MEDLINE DCOM- 20130520 LR - 20211021 IS - 1873-1570 (Electronic) IS - 0300-9572 (Print) IS - 0300-9572 (Linking) VI - 83 IP - 8 DP - 2012 Aug TI - Coenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patients. PG - 991-5 LID - 10.1016/j.resuscitation.2012.03.023 [doi] AB - AIM: Survival after cardiac arrest (CA) is limited by the profound neurologic insult from ischemia-reperfusion injury. Therapeutic options are limited. Previous data suggest a benefit of coenzyme Q(10) (CoQ(10)) in post-arrest patients. We hypothesized that plasma CoQ(10) levels would be low after CA and associated with poorer outcomes. METHODS: Prospective observational study of post-arrest patients presenting to a tertiary care center. CoQ(10) levels were drawn 24h after return of spontaneous circulation (ROSC) and compared to healthy controls. Levels of inflammatory cytokines and biomarkers were analyzed. Primary endpoints were survival to discharge and neurologic status at time of discharge. RESULTS: 23 CA subjects and 16 healthy controls were enrolled. CoQ(10) levels in CA patients (0.28 mumol L(-1), inter-quartile range (IQR): 0.22-0.39) were significantly lower than in controls (0.75 mumol L(-1), IQR: 0.61-1.08, p<0.0001). The mean CoQ(10) level in CA patients who died was significantly lower than in those who survived (0.27 vs 0.47 mumol L(-1), p = 0.007). There was a significant difference in median CoQ(10) level between patients with a good vs poor neurological outcome (0.49 mumol L(-1), IQR: 0.30-0.67 vs 0.27 mumol L(-1), IQR: 0.21-0.30, p = 0.02). CoQ(10) was a statistically significant predictor of poor neurologic outcome (adjusted p = 0.02) and in-hospital mortality (adjusted p = 0.026). CONCLUSION: CoQ(10) levels are low in human subjects with ROSC after cardiac arrest as compared to healthy controls. CoQ(10) levels were lower in those who died, as well as in those with a poor neurologic outcome. CI - Copyright (c) 2012 Elsevier Ireland Ltd. All rights reserved. FAU - Cocchi, Michael N AU - Cocchi MN AD - Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States. mcocchi@bidmc.harvard.edu FAU - Giberson, Brandon AU - Giberson B FAU - Berg, Katherine AU - Berg K FAU - Salciccioli, Justin D AU - Salciccioli JD FAU - Naini, Ali AU - Naini A FAU - Buettner, Catherine AU - Buettner C FAU - Akuthota, Praveen AU - Akuthota P FAU - Gautam, Shiva AU - Gautam S FAU - Donnino, Michael W AU - Donnino MW LA - eng GR - F32 AI081513/AI/NIAID NIH HHS/United States GR - K23 AR055664/AR/NIAMS NIH HHS/United States GR - NIH K23AR055664/AR/NIAMS NIH HHS/United States GR - UL1 RR025758/RR/NCRR NIH HHS/United States GR - NIH F32AI081513/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120328 PL - Ireland TA - Resuscitation JT - Resuscitation JID - 0332173 RN - 0 (Biomarkers) RN - 0 (Cytokines) RN - 1339-63-5 (Ubiquinone) RN - EJ27X76M46 (coenzyme Q10) SB - IM CIN - Resuscitation. 2012 Aug;83(8):928-9. PMID: 22640977 MH - Aged MH - Biomarkers/blood MH - Cytokines/*blood MH - Female MH - Heart Arrest/*blood/mortality MH - Hospital Mortality MH - Humans MH - Male MH - Middle Aged MH - Outcome Assessment, Health Care MH - Patient Discharge MH - Prospective Studies MH - Survival Analysis MH - Ubiquinone/*analogs & derivatives/blood PMC - PMC3658101 MID - NIHMS459895 COIS- Conflict of interest statement None of the authors declare any conflict of interests. EDAT- 2012/04/03 06:00 MHDA- 2013/05/22 06:00 PMCR- 2013/05/20 CRDT- 2012/04/03 06:00 PHST- 2011/09/22 00:00 [received] PHST- 2012/02/28 00:00 [revised] PHST- 2012/03/12 00:00 [accepted] PHST- 2012/04/03 06:00 [entrez] PHST- 2012/04/03 06:00 [pubmed] PHST- 2013/05/22 06:00 [medline] PHST- 2013/05/20 00:00 [pmc-release] AID - S0300-9572(12)00173-6 [pii] AID - 10.1016/j.resuscitation.2012.03.023 [doi] PST - ppublish SO - Resuscitation. 2012 Aug;83(8):991-5. doi: 10.1016/j.resuscitation.2012.03.023. Epub 2012 Mar 28.